Invention Grant
- Patent Title: Antibody molecule-drug conjugates and uses thereof
-
Application No.: US16478696Application Date: 2018-01-18
-
Publication No.: US11890319B2Publication Date: 2024-02-06
- Inventor: Zachary Shriver , Obadiah Joseph Plante , Kai Li , Karthik Viswanathan , James C. Delaney , Boopathy Ramakrishnan , Andrew M. Wollacott
- Applicant: VISTERRA, INC.
- Applicant Address: US MA Waltham
- Assignee: VISTERRA, INC.
- Current Assignee: VISTERRA, INC.
- Current Assignee Address: US MA Waltham
- Agency: K&L Gates LLP
- International Application: PCT/US2018/014224 2018.01.18
- International Announcement: WO2018/136626A 2018.07.26
- Date entered country: 2019-07-17
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/17 ; A61K47/68 ; A61P31/04 ; C07K16/12
Abstract:
Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.
Public/Granted literature
- US20210283220A1 ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF Public/Granted day:2021-09-16
Information query
IPC分类:
